Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Finasteride causes temporary cell death in BPH tissues.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Puerariae Flos extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.